Developer docs
API playgroundTry for free, no card

Search company profiles

Aidoc

Full company profile

uuid0000255

Namestring
Aidoc
Legal namestring
Aidoc Medical Ltd.
Websiteurl
aidoc.com
Company typeenum
Private
Founded yearint
2016
Descriptiontext

Aidoc is a clinical artificial intelligence company founded in 2016 in Tel Aviv, Israel, that develops AI-powered software for healthcare imaging and clinical workflows. The company sells an enterprise SaaS platform — the aiOS Clinical AI Operating System — and a proprietary foundation model called CARE (Clinical AI Reasoning Engine), trained on multimodal data (imaging, clinical notes, lab results) via self-supervised learning. On top of these core technologies, Aidoc delivers specialty AI applications across radiology (largest FDA-cleared portfolio), cardiology (coronary artery disease, echocardiography), neurovascular (stroke, hemorrhage, aneurysm, spine), and vascular (PE, DVT, aortic disease, IVC filters), with add-on modules for care coordination and patient management. The platform also operates as a multi-vendor AI marketplace, with 69% of customers running non-Aidoc models on aiOS alongside native solutions.

The company distributes exclusively through enterprise direct sales to large health systems and hospital networks globally, employing a field sales motion with pilots that transition to enterprise-wide deployments under multi-year subscription contracts. Aidoc's platform is deployed at nearly 2,000 hospitals and more than 150 health systems across 19 countries, analyzing over 60 million patient cases annually (120 million+ cumulatively), with documented customers including Mercy, WellSpan Health, Mount Sinai, Hartford HealthCare, Northwell Health, Sutter Health, Houston Methodist, and Asklepios Group. The company has raised over $500 million in total funding — including a $150 million Series E in April 2026 led by Goldman Sachs Alternatives at a $5 billion post-money valuation — and is positioning for a potential IPO in 2026-2027. Aidoc holds 14 FDA-cleared acute indications (including the industry's first comprehensive foundation-model-powered triage clearance), two FDA Breakthrough Device Designations, CE marking, and compliance with MDSAP, ISO 13485, EU MDR, HIPAA, and GDPR.

Short descriptiontext

Aidoc is an enterprise clinical AI company that provides the aiOS platform and CARE foundation model for medical imaging triage and care coordination across radiology, cardiology, neurovascular, and vascular workflows, deployed at nearly 2,000 hospitals and 150+ health systems in 19 countries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersTel Aviv, Israel
HQ citystring
Tel Aviv
HQ countrystring
Israel
HQ regionstring
Middle East
Markets served

Serves global market

Offices4 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical AI platform, medical imaging AI, radiology triage software, healthcare AI solutions, enterprise clinical AI
Industry3 codes
1AI Integration & Orchestration Platforms (Connectors, Workflow, iPaaS for AI)
CodeHDAEANAIPrimaryYes
2AI Application Enablement Platforms (Copilot/Agent Frameworks, SDKs)
CodeHDAEANAJPrimaryNo
3End-to-End Enterprise AI Platforms (MLOps & Model Lifecycle Management)
CodeHDAEANAAPrimaryNo
NAICS code1 code
  • Computer Systems Design and Related Services54151
SIC code2 codes
  • Services-Prepackaged Software7372
  • Services-Computer Integrated Systems Design7373
Product category
Clinical AI Software for Healthcare Imaging
Social media profiles3 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Clinical AI Platform Subscription
TypeSubscription Recurring
Description

Aidoc operates on a subscription-based SaaS model targeting health systems and hospitals. The platform is deployed enterprise-wide across health systems with annual or multi-year contracts. Revenue is generated through licensing the aiOS platform and individual AI applications for clinical workflows including radiology triage, cardiology, neurovascular, and vascular care coordination.

aidoc.com
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Infrastructure, Marketing or Sales, Operations
Pricing details1 tier
1Enterprise platform licensing with custom pricing based on health system scope
ModelSubscriptionBilling cadenceMulti-year contract
Notes

Custom enterprise pricing; no public pricing listed

aidoc.com
GTM typeB2B
B2B
Offering typeSoftware
Software
Brand1 of 4 records shown
1aiOS
Description

Aidoc's proprietary enterprise AI platform that enables deployment and governance of clinical AI at scale across health systems

aidoc.com
+3 more records
Core offering1 text field

Aidoc develops and sells the aiOS clinical AI operating system and CARE foundation model, an enterprise SaaS platform that deploys FDA-cleared AI applications for radiology triage, cardiology, neurovascular, and vascular care coordination across hospital networks. The platform supports both Aidoc's proprietary AI algorithms and third-party AI models, enabling health systems to operationalize clinical AI at scale with intelligent orchestration, performance monitoring, and care coordination workflows.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 15 values shown
  • 31% faster time-to-notification for PE patients
+14 more records
Product overview1 text field

Aidoc offers a unified clinical AI platform architecture consisting of aiOS (the enterprise operating system) and CARE (the foundation model), with specialized AI solutions across four clinical domains: Radiology (medical imaging analysis and triage), Cardiology (coronary artery disease and echocardiography), Neurovascular (stroke, hemorrhage, brain aneurysm, spine), and Vascular (PE, DVT, aortic diseases, IVC filters). The platform provides end-to-end capabilities including intelligent orchestration, care coordination tools, patient management, and governance/analytics. Aidoc operates a partner ecosystem where 69% of customers run non-Aidoc models on aiOS alongside native solutions. The company has received multiple FDA clearances including the industry's first comprehensive foundation model AI for abdomen CT triage covering 14 acute indications.

Product and service8 records
1aiOS (AI Operating System)
CategoryEnterprise Clinical AI Platform
Description

Proprietary enterprise AI platform that enables health systems to deploy, orchestrate, and govern clinical AI solutions at scale. Provides intelligent orchestration, real-time performance monitoring, outcome measurement, and PACS/EHR integration for both Aidoc and third-party AI models.

2CARE (Clinical AI Reasoning Engine)
CategoryFoundation Model
Description

Clinical-grade foundation model trained on multimodal data (imaging, clinical notes, lab results) using self-supervised learning. Powers FDA-cleared applications and enables development of new clinical indications up to 20x faster than traditional single-task models.

3Radiology AI Solutions
CategoryClinical AI Solution - Radiology
Description

Automated medical imaging analysis to streamline workflows, prioritize findings, activate care teams, and facilitate patient follow-up across emergency, inpatient, and outpatient settings.

4Cardiology AI Solutions
CategoryClinical AI Solution - Cardiology
Description

Imaging and text-based AI insights for automated coronary artery disease detection and echocardiography analysis to consistently measure disease and capture incidental cardiac findings.

5Neurovascular AI Solutions
CategoryClinical AI Solution - Neurovascular
Description

High-performing algorithms for stroke, hemorrhage, c-spine fracture, and brain aneurysm detection paired with care coordination tools and real-time notification with clinical context from EHR.

6Vascular AI Solutions
CategoryClinical AI Solution - Vascular
Description

Workflow streamlining and care coordination for aortic diseases, pulmonary embolism (PE), deep vein thrombosis (DVT), and IVC filter management with centralized patient management.

7Comprehensive Abdomen CT Triage
CategoryFDA-Cleared Triage Application
Description

FDA-cleared comprehensive AI triage solution covering 14 acute indications (11 newly cleared + 3 previously cleared) from a single abdomen CT scan, powered by CARE foundation model. Includes aortic dissection, appendicitis, bowel obstructions, and 11 other conditions.

8First Read
CategoryAI Radiology Reporting Tool
Description

Investigational AI tool that analyzes chest radiographs and generates preliminary radiology report text for radiologist review. Designed to address radiology interpretation bottlenecks where turnaround times more than doubled between 2014 and 2023.

Scale indicator10 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Strategic initiative through NVentures for high-performance compute and AI development platforms. Aidoc plans to invest over $150M combining NVIDIA compute with AWS platforms to redefine CARE model performance, efficiency, and real-time inference.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Strategic cloud partnership for clinical AI platform deployment. Aidoc announced dedicated AWS collaboration as part of foundation model development strategy.

Strategic tierStrategicTypeStrategic or Co-development Partner
Description

Enterprise-wide rollout announced as part of $150M Series E announcement. One of the largest health system deployments of Aidoc platform.

Strategic tierStrategicTypeStrategic or Co-development Partner
Description

Case studies from Amsterdam, Sweden, and Germany demonstrating AI's real-world impact on triage efficiency. Includes Isala Hospital (Netherlands) first AI-powered PE Response, Asklepios Group Germany 28-hospital deployment, and Stradins Hospital Latvia.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Qure.ai develops deep learning models for radiology, including head CT, chest X-ray, and tuberculosis screening, with multiple FDA clearances. It directly competes with Aidoc in radiology AI triage, though with a broader global health focus including emerging markets.

TypeDirect peer
Description

Arterys (now Tempus) provides cloud-native AI medical imaging platform with FDA-cleared applications for cardiac MR, oncology, and lung CT. It directly competes with Aidoc in AI-powered imaging analysis, though it has expanded its focus to broader AI applications through Tempus.

TypeEmerging player
Description

Annalise.ai offers comprehensive radiology AI covering 130+ findings on chest X-rays, with growing US health system deployments. It is an emerging competitor to Aidoc in multi-finding radiology triage, with a more focused product line on comprehensive X-ray interpretation.

TypeDirect peer
Description

HeartFlow provides AI-driven coronary CT angiography analysis for non-invasive assessment of coronary artery disease, directly competing with Aidoc's cardiology solutions. Both target large health systems and have achieved meaningful commercial traction.

TypeEmerging player
Description

Nanox acquired Zebra Medical Vision and now offers AI imaging analytics for radiology, including bone health, breast cancer, and lung disease. It competes with Aidoc in AI-driven imaging interpretation, though with a different commercial model focused on global screening and population health.

TypeBroad incumbent
Description

Siemens Healthineers offers AI-Rad Companion for radiology AI, integrated into its imaging modality and PACS infrastructure. It competes with Aidoc as a broad incumbent leveraging installed imaging equipment and health system contracts to deliver AI capabilities.

TypeBroad incumbent
Description

Philips offers IntelliSpace AI and HealthSuite platform, integrating clinical AI into PACS, imaging, and patient monitoring workflows. As a broad incumbent with deep health system relationships, it competes with Aidoc for enterprise AI budgets and can bundle AI into existing contracts.

TypeDirect peer
Description

RapidAI provides AI solutions for stroke, aneurysm, and PE detection and care coordination, directly competing with Aidoc in neurovascular and vascular AI applications. Both companies target large health systems with imaging-based triage and care coordination workflows.

TypeDirect peer
Description

Viz.ai is a direct competitor focused on AI-powered care coordination, particularly in stroke and neurovascular care, with FDA-cleared algorithms for large vessel occlusion detection. Like Aidoc, it targets large health systems with enterprise sales and has raised over $250M, competing head-to-head in the same hospital AI budgets.

TypeBroad incumbent
Description

GE HealthCare is a broad incumbent offering the Edison platform, integrating AI into imaging modalities, PACS, and enterprise imaging solutions. It competes with Aidoc by bundling clinical AI capabilities into installed imaging and PACS infrastructure, with a far larger installed base and budget relationships.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat8 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers17 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment5 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

Integration3 records

Each record includes

Title, Type, Description, Source

AI capability8 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles11 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance8 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds12 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors18 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Aidoc

Clinical AI Software for Healthcare Imagingaidoc.com

Aidoc is an enterprise clinical AI company that provides the aiOS platform and CARE foundation model for medical imaging triage and care coordination across radiology, cardiology, neurovascular, and vascular workflows, deployed at nearly 2,000 hospitals and 150+ health systems in 19 countries.

What Aidoc does

Aidoc is a clinical artificial intelligence company founded in 2016 in Tel Aviv, Israel, that develops AI-powered software for healthcare imaging and clinical workflows. The company sells an enterprise SaaS platform — the aiOS Clinical AI Operating System — and a proprietary foundation model called CARE (Clinical AI Reasoning Engine), trained on multimodal data (imaging, clinical notes, lab results) via self-supervised learning. On top of these core technologies, Aidoc delivers specialty AI applications across radiology (largest FDA-cleared portfolio), cardiology (coronary artery disease, echocardiography), neurovascular (stroke, hemorrhage, aneurysm, spine), and vascular (PE, DVT, aortic disease, IVC filters), with add-on modules for care coordination and patient management. The platform also operates as a multi-vendor AI marketplace, with 69% of customers running non-Aidoc models on aiOS alongside native solutions.

The company distributes exclusively through enterprise direct sales to large health systems and hospital networks globally, employing a field sales motion with pilots that transition to enterprise-wide deployments under multi-year subscription contracts. Aidoc's platform is deployed at nearly 2,000 hospitals and more than 150 health systems across 19 countries, analyzing over 60 million patient cases annually (120 million+ cumulatively), with documented customers including Mercy, WellSpan Health, Mount Sinai, Hartford HealthCare, Northwell Health, Sutter Health, Houston Methodist, and Asklepios Group. The company has raised over $500 million in total funding — including a $150 million Series E in April 2026 led by Goldman Sachs Alternatives at a $5 billion post-money valuation — and is positioning for a potential IPO in 2026-2027. Aidoc holds 14 FDA-cleared acute indications (including the industry's first comprehensive foundation-model-powered triage clearance), two FDA Breakthrough Device Designations, CE marking, and compliance with MDSAP, ISO 13485, EU MDR, HIPAA, and GDPR.

Aidoc firmographics

Firmographics
Name
Aidoc
Legal name
Aidoc Medical Ltd.
Website
https://aidoc.com
Company type
Private
Founded year
2016
Operating status
Operating
Headcount range
251–500 employees
Short description
Aidoc is an enterprise clinical AI company that provides the aiOS platform and CARE foundation model for medical imaging triage and care coordination across radiology, cardiology, neurovascular, and vascular workflows, deployed at nearly 2,000 hospitals and 150+ health systems in 19 countries.
Ownership category
akta.pro rank

Aidoc industry classification

Industry
Product category
Clinical AI Software for Healthcare Imaging
NAICS
Computer Systems Design and Related Services (54151)
SIC
Services-Prepackaged Software (7372), Services-Computer Integrated Systems Design (7373)
akta.pro primary industry
AI Integration & Orchestration Platforms (Connectors, Workflow, iPaaS for AI) (HDAEANAI)
akta.pro secondary industries
AI Application Enablement Platforms (Copilot/Agent Frameworks, SDKs) (HDAEANAJ), End-to-End Enterprise AI Platforms (MLOps & Model Lifecycle Management) (HDAEANAA)

Keywords

  • Clinical AI platform
  • Medical imaging AI
  • Radiology triage software
  • Healthcare AI solutions
  • Enterprise clinical AI

Where Aidoc is headquartered

Location

Headquarters

HQ city
Tel Aviv
HQ country
Israel
HQ region
Middle East

Offices4 records

Markets served

Aidoc business model

Business model
GTM type
B2B
Offering type
Software
Cost components
Personnel, Technology or R&D, Infrastructure, Marketing or Sales, Operations

Revenue model

  1. Clinical AI Platform Subscription: Aidoc operates on a subscription-based SaaS model targeting health systems and hospitals. The platform is deployed enterprise-wide across health systems with annual or multi-year contracts. Revenue is generated through licensing the aiOS platform and individual AI applications for clinical workflows including radiology triage, cardiology, neurovascular, and vascular care coordination.

Pricing tiers

ModelBillingPrice
SubscriptionMulti-year contractEnterprise platform licensing with custom pricing based on health system scope

Go-to-market motion1 record

Distribution channels1 record

Marketing channels8 records

Aidoc product offering

Product offering

Core offering

Aidoc develops and sells the aiOS clinical AI operating system and CARE foundation model, an enterprise SaaS platform that deploys FDA-cleared AI applications for radiology triage, cardiology, neurovascular, and vascular care coordination across hospital networks. The platform supports both Aidoc's proprietary AI algorithms and third-party AI models, enabling health systems to operationalize clinical AI at scale with intelligent orchestration, performance monitoring, and care coordination workflows.

Product overview

Aidoc offers a unified clinical AI platform architecture consisting of aiOS (the enterprise operating system) and CARE (the foundation model), with specialized AI solutions across four clinical domains: Radiology (medical imaging analysis and triage), Cardiology (coronary artery disease and echocardiography), Neurovascular (stroke, hemorrhage, brain aneurysm, spine), and Vascular (PE, DVT, aortic diseases, IVC filters). The platform provides end-to-end capabilities including intelligent orchestration, care coordination tools, patient management, and governance/analytics. Aidoc operates a partner ecosystem where 69% of customers run non-Aidoc models on aiOS alongside native solutions. The company has received multiple FDA clearances including the industry's first comprehensive foundation model AI for abdomen CT triage covering 14 acute indications.

Differentiator

Problem solved

Functional benefit

Brands

  • aiOS: Aidoc's proprietary enterprise AI platform that enables deployment and governance of clinical AI at scale across health systems
  • CARE
  • aiOS
  • aiOS™

Products and services

  • aiOS (AI Operating System) Proprietary enterprise AI platform that enables health systems to deploy, orchestrate, and govern clinical AI solutions at scale. Provides intelligent orchestration, real-time performance monitoring, outcome measurement, and PACS/EHR integration for both Aidoc and third-party AI models.
  • CARE (Clinical AI Reasoning Engine) Clinical-grade foundation model trained on multimodal data (imaging, clinical notes, lab results) using self-supervised learning. Powers FDA-cleared applications and enables development of new clinical indications up to 20x faster than traditional single-task models.
  • Radiology AI Solutions Automated medical imaging analysis to streamline workflows, prioritize findings, activate care teams, and facilitate patient follow-up across emergency, inpatient, and outpatient settings.
  • Cardiology AI Solutions Imaging and text-based AI insights for automated coronary artery disease detection and echocardiography analysis to consistently measure disease and capture incidental cardiac findings.
  • Neurovascular AI Solutions High-performing algorithms for stroke, hemorrhage, c-spine fracture, and brain aneurysm detection paired with care coordination tools and real-time notification with clinical context from EHR.
  • Vascular AI Solutions Workflow streamlining and care coordination for aortic diseases, pulmonary embolism (PE), deep vein thrombosis (DVT), and IVC filter management with centralized patient management.
  • Comprehensive Abdomen CT Triage FDA-cleared comprehensive AI triage solution covering 14 acute indications (11 newly cleared + 3 previously cleared) from a single abdomen CT scan, powered by CARE foundation model. Includes aortic dissection, appendicitis, bowel obstructions, and 11 other conditions.
  • First Read Investigational AI tool that analyzes chest radiographs and generates preliminary radiology report text for radiologist review. Designed to address radiology interpretation bottlenecks where turnaround times more than doubled between 2014 and 2023.

Quantifiable outcome

  • 31% faster time-to-notification for PE patients
  • +14 more outcomes

Companies that use Aidoc

Customer profile

Named customers17 records

Segments5 records

Ideal customer profiles3 records

Aidoc technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Integration3 records

AI capability8 records

Feature5 records

Aidoc partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered core and strategic.

  • NVIDIAcoreStrategic or Co-development PartnerStrategic initiative through NVentures for high-performance compute and AI development platforms. Aidoc plans to invest over $150M combining NVIDIA compute with AWS platforms to redefine CARE model performance, efficiency, and real-time inference.
  • AWS (Amazon Web Services)coreStrategic or Co-development PartnerStrategic cloud partnership for clinical AI platform deployment. Aidoc announced dedicated AWS collaboration as part of foundation model development strategy.
  • Advocate HealthstrategicStrategic or Co-development PartnerEnterprise-wide rollout announced as part of $150M Series E announcement. One of the largest health system deployments of Aidoc platform.
  • European Health Systems (Germany, Netherlands, Sweden)strategicStrategic or Co-development PartnerCase studies from Amsterdam, Sweden, and Germany demonstrating AI's real-world impact on triage efficiency. Includes Isala Hospital (Netherlands) first AI-powered PE Response, Asklepios Group Germany 28-hospital deployment, and Stradins Hospital Latvia.

Scale indicators10 records

Recent moves6 records

Expansion highlights6 records

Aidoc competitors and assessment

Company assessment

Direct peers

  • Qure.ai: Qure.ai develops deep learning models for radiology, including head CT, chest X-ray, and tuberculosis screening, with multiple FDA clearances. It directly competes with Aidoc in radiology AI triage, though with a broader global health focus including emerging markets.
  • Arterys: Arterys (now Tempus) provides cloud-native AI medical imaging platform with FDA-cleared applications for cardiac MR, oncology, and lung CT. It directly competes with Aidoc in AI-powered imaging analysis, though it has expanded its focus to broader AI applications through Tempus.
  • HeartFlow: HeartFlow provides AI-driven coronary CT angiography analysis for non-invasive assessment of coronary artery disease, directly competing with Aidoc's cardiology solutions. Both target large health systems and have achieved meaningful commercial traction.
  • RapidAI: RapidAI provides AI solutions for stroke, aneurysm, and PE detection and care coordination, directly competing with Aidoc in neurovascular and vascular AI applications. Both companies target large health systems with imaging-based triage and care coordination workflows.
  • Viz.ai: Viz.ai is a direct competitor focused on AI-powered care coordination, particularly in stroke and neurovascular care, with FDA-cleared algorithms for large vessel occlusion detection. Like Aidoc, it targets large health systems with enterprise sales and has raised over $250M, competing head-to-head in the same hospital AI budgets.

Emerging players

  • Annalise.ai: Annalise.ai offers comprehensive radiology AI covering 130+ findings on chest X-rays, with growing US health system deployments. It is an emerging competitor to Aidoc in multi-finding radiology triage, with a more focused product line on comprehensive X-ray interpretation.
  • Nanox (formerly Zebra Medical Vision): Nanox acquired Zebra Medical Vision and now offers AI imaging analytics for radiology, including bone health, breast cancer, and lung disease. It competes with Aidoc in AI-driven imaging interpretation, though with a different commercial model focused on global screening and population health.

Broad incumbents

  • Siemens Healthineers AI-Rad Companion: Siemens Healthineers offers AI-Rad Companion for radiology AI, integrated into its imaging modality and PACS infrastructure. It competes with Aidoc as a broad incumbent leveraging installed imaging equipment and health system contracts to deliver AI capabilities.
  • Philips HealthSuite: Philips offers IntelliSpace AI and HealthSuite platform, integrating clinical AI into PACS, imaging, and patient monitoring workflows. As a broad incumbent with deep health system relationships, it competes with Aidoc for enterprise AI budgets and can bundle AI into existing contracts.
  • GE HealthCare: GE HealthCare is a broad incumbent offering the Edison platform, integrating AI into imaging modalities, PACS, and enterprise imaging solutions. It competes with Aidoc by bundling clinical AI capabilities into installed imaging and PACS infrastructure, with a far larger installed base and budget relationships.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat8 records

Key risks6 records

Key highlights7 records

Customer concentration

Aidoc social profiles

Digital presence

Aidoc compliance and trust

Trust signal

Compliance8 records

Aidoc financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Aidoc leadership team

Management profile

Number of profiles

Profiles11 records

Aidoc funding detail

Funding detail

Funding overview

Funding rounds12 records

Investors18 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Aidoc M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Aidoc

What does Aidoc do?

Aidoc develops and sells the aiOS clinical AI operating system and CARE foundation model, an enterprise SaaS platform that deploys FDA-cleared AI applications for radiology triage, cardiology, neurovascular, and vascular care coordination across hospital networks. The platform supports both Aidoc's proprietary AI algorithms and third-party AI models, enabling health systems to operationalize clinical AI at scale with intelligent orchestration, performance monitoring, and care coordination workflows.

Is Aidoc a public or private company?

Aidoc is a private company. It is classified as venture growth investor backed and is currently operating.

When was Aidoc founded?

Aidoc was founded in 2016. It employs 251 to 500 people.

Where is Aidoc based?

Aidoc is headquartered in Tel Aviv, Israel, in the Middle East region.

How does Aidoc make money?

One revenue line is on record: clinical AI Platform Subscription.

Who are Aidoc's main competitors?

Direct peers on record are Qure.ai, Arterys, HeartFlow, RapidAI and Viz.ai. Emerging players are Annalise.ai and Nanox (formerly Zebra Medical Vision). Broad incumbents are Siemens Healthineers AI-Rad Companion, Philips HealthSuite and GE HealthCare.

Does Aidoc have an API?

No public API is recorded for Aidoc.

What industry is Aidoc in?

Aidoc's product category is Clinical AI Software for Healthcare Imaging. Its primary akta.pro industry code is HDAEANAI, AI Integration & Orchestration Platforms (Connectors, Workflow, iPaaS for AI), with a secondary code of HDAEANAJ, AI Application Enablement Platforms (Copilot/Agent Frameworks, SDKs). Its NAICS code is 54151 and its SIC code is 7372.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Medical BuyerTwelve US hospitals, Aidocto partner for AI diagnostic consortiumTwelve US hospital systems partnered with Aidoc to form the Diagnostic AI Consortium, aiming to share best practices and develop AI diagnostic tools. The consortium includes major health systems like Advocate Health and Cedars-Sinai, with plans to publish an adoption playbook. Leaders expect significant progress within a year.Medical BuyerCMS approves NTAP designation for Aidoc’s AI diagnostic techCMS approved an NTAP designation for Aidoc's AI diagnostic tool CARE Body CT Multi-Triage on August 13, 2026, the first for an AI-enabled diagnostic. Hospitals can receive supplemental payments starting October 1, 2026, for three years. The designation may encourage broader adoption of AI technologies.BeckershospitalreviewAI helps radiologists detect 39% more brain aneurysm cases: 5 notesAn FDA-cleared AI tool from Aidoc helped radiologists detect 39% more brain aneurysms on CT angiography exams, according to a study published Sept. 8 in the Journal of the American College of Radiology. The AI identified 55 true-positive cases missed by radiologists, with 84.6% sensitivity versus 71.8% for radiologists.PressdemocratHow a Bay Area healthcare system is navigating AI by balancing tech upgrades and patient trustSutter Health, a Bay Area healthcare system, is expanding AI use in clinical care, partnering with Aidoc and OpenEvidence, and launching a patient chatbot. It also plans to open the Bay Area's first new medical school in over a century, centered on AI technologies.The Mercury NewsHow a Bay Area healthcare system is navigating AI by balancing tech upgrades and patient trustSutter Health, a Bay Area healthcare system, is expanding AI use in clinical care, partnering with Aidoc and OpenEvidence, and launching a patient chatbot. It also plans to open the Bay Area's first new medical school in over a century, centered on AI technologies.Mpo-magFDA Breakthrough Device Designation Granted to AI Tech That Drafts Radiology ReportsAidoc received FDA Breakthrough Device Designation for First Read, an AI tool that analyzes chest radiographs and drafts preliminary radiology reports. The designation follows a $150 million Series E financing and deployment across nearly 2,000 hospitals. The tool is investigational and has not been cleared or approved by the FDA.PR NewswireMedical Image Analysis Software Market worth $6.42 billion by 2031 - Exclusive Report by MarketsandMarkets™The medical image analysis software market is projected to grow from USD 4.35 billion in 2026 to USD 6.42 billion by 2031, an 8.1% CAGR. North America held the largest regional share at 38.4% in 2025, and the integrated software segment accounted for 64.5% of the market. AI-enabled technology is expected to see the fastest growth at 8.6% CAGR.PR NewswireMercy and Aidoc Reveal Faster Diagnoses and Earlier Treatment for Thousands of PatientsA white paper from Mercy, Aidoc, and AVIA reports that AI imaging technology flagged 50,749 incidental findings in five months, with 5,642 patients receiving accelerated attention. Scan-to-result turnaround time dropped from 19.8 to 1.3 hours, and the system now analyzes about 2.5 million cases annually. Mercy aims to achieve Joint Commission certification for responsible AI governance.HklawCMS Greenlights Enhanced Payments for AI Technology in CT ImagingCMS approved a New Technology Add-On Payment (NTAP) for Aidoc's AI diagnostic tool CARE Body CT Multi-Triage, the first NTAP for an AI-enabled diagnostic. Hospitals can receive supplemental payments starting October 1, 2026, for three years. The tool uses AI to prioritize urgent CT findings in chest, abdomen, and pelvis.MorningstarAidoc's CARE Body CT Multi-Triage receives eligibility for Medicare New Technology Add-on PaymentCMS approved a Medicare New Technology Add-on Payment for Aidoc's CARE Body CT Multi-Triage, effective October 1, 2026. The add-on payment covers eligible inpatient use of the FDA-cleared AI triage technology for abdominal CT cases. The decision follows FDA clearance and Breakthrough Device Designation, aiming to offset adoption costs.